Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 19,434 shares at $44.77 ($875K) on 2025-07-02, disclosed to the SEC on 2025-07-03.
Scheduled sale ($875k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.77 | 6,409 | $287K | 32.8% |
| 2 | $44.77 | 6,409 | $287K | 32.8% |
| 3 | $45.49 | 2,935 | $134K | 15.3% |
| 4 | $45.49 | 2,935 | $134K | 15.3% |
| 5 | $46.26 | 746 | $35K | 3.9% |
| Total | $45.04 avg | 19,434 |
| $875K |
| 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |